Tivic Health Systems (Tivic Health Systems) Debt-to-Equity : 0.10 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Tivic Health Systems Debt-to-Equity?

Tivic Health Systems's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.19 Mil. Tivic Health Systems's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.18 Mil. Tivic Health Systems's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $3.58 Mil. Tivic Health Systems's debt to equity for the quarter that ended in Dec. 2023 was 0.10.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Tivic Health Systems's Debt-to-Equity or its related term are showing as below:

TIVC' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.25 Med: 0.08 Max: 0.15
Current: 0.1

During the past 5 years, the highest Debt-to-Equity Ratio of Tivic Health Systems was 0.15. The lowest was -1.25. And the median was 0.08.

TIVC's Debt-to-Equity is ranked better than
68.41% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs TIVC: 0.10

Tivic Health Systems Debt-to-Equity Historical Data

The historical data trend for Tivic Health Systems's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tivic Health Systems Debt-to-Equity Chart

Tivic Health Systems Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

-1.25

0.05

0.15

0.10

Tivic Health Systems Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial										0.15	0.10	0.15	0.07	0.10

Competitive Comparison of Tivic Health Systems's Debt-to-Equity

For the Medical Devices subindustry, Tivic Health Systems's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tivic Health Systems's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tivic Health Systems's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Tivic Health Systems's Debt-to-Equity falls into.

Tivic Health Systems Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Tivic Health Systems's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.193	+	0.176)	/	3.58
	=	0.10

Tivic Health Systems's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.193	+	0.176)	/	3.58
	=	0.10

Tivic Health Systems (NAS:TIVC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Tivic Health Systems Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Tivic Health Systems's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Tivic Health Systems (Tivic Health Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tivic Health Systems Inc (NAS:TIVC) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

25821 Industrial Boulevard, Suite 100, Hayward, CA, USA, 94545

Website

https://www.tivichealth.com

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

Executives

Sheryle Bolton	director	55 ALMADEN BLVD, SAN JOSE CA 95113
Dean Zikria	director	C/O INTUITY MEDICAL, INC., 3500 WEST WARREN AVENUE, FREMONT CA 94538
Jennifer Ernst	director, officer: Chief Executive Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Blake Gurfein	officer: Chief Scientific Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Ryan Sabia	officer: Chief Operating Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Kimberly Ann Bambach	officer: Interim CFO	25821 INDUSTRIAL BLVD., SUITE 100, HAYWARD CA 94545
Karen Drexler	director	C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Veronica Cai	officer: Chief Financial Officer	C/O CATALYST BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 710, SOUTH SAN FRANCISCO CA 94080
John Claude	10 percent owner	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Briana Benz	officer: Chief Financial Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025